• LOGIN
  • SUBSCRIBE
  • FREE E-Newsletter/Product Bulletins

Cath Lab Digest

  • Follow us on
  • Home
  • About Us
    • Privacy Policy/Copyright
    • About VDM
    • Editorial Board
    • Contact
  • Issues
    • Current Issue
    • Issue Archives
  • Multimedia
  • Editor's Update
  • Advertise
  • Reprints
  • Authors & Reviewers
    • Author Instructions
    • Submission Portal
    • Reviewers

Search

Vascular Newswire

  • Medtronic IN.PACT Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries
    Thu, 05/23/13 - 3:30pm
  • Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
    Thu, 05/23/13 - 3:15pm
  • One-Year Data Demonstrates Safe, Rapid, and Sustained Blood Pressure Reduction With EnligHTN Renal Denervation Technology
    Thu, 05/23/13 - 3:14pm
  • Further Data on STENTYS Self-Apposing Stent Reinforces Strength of Clinical Results
    Thu, 05/23/13 - 3:05pm
  • Cardiovascular Systems Presents New Late-Breaking Coronary Results at EuroPCR Conference
    Thu, 05/23/13 - 1:30pm
  • New Data Demonstrate Significant and Sustained Blood Pressure Reduction With Boston Scientific Vessix Renal Denervation System
    Thu, 05/23/13 - 11:50am
  • Volcano Announces ADVISE II Study Results and Inclusion in the SYNTAX2 Trial at EuroPCR 2013
    Thu, 05/23/13 - 11:42am
  • Terumo Medical Corporation Obtains Withdrawal by Vascular Solutions of the R-Band Radial Hemostasis Device
    Wed, 05/22/13 - 1:28pm
  • Resolute Stent Delivers Strong Long-Term Results for Bifurcations in Coronary Arteries
    Wed, 05/22/13 - 11:04am
  • Excellent 6-Month Results for CE-Marked Fully Bioresorbable DESolve Novolimus-Eluting Coronary Scaffold System Announced at EuroPCR
    Wed, 05/22/13 - 10:59am
  • Cordis Showcases New Cardiovascular Innovations at EuroPCR 2013
    Tue, 05/21/13 - 10:13am
  • Verrata Pressure Guide Wire and iFR (Instant Wave-Free Ratio) Software Modality on Display at EuroPCR 2013
    Tue, 05/21/13 - 9:36am
  • Abbott Announces CE Mark for World's Longest Coronary Drug Eluting Stent
    Tue, 05/21/13 - 9:27am
  • First Clinical Research Published on Frequency and Composition of Embolic Debris Captured During TAVR
    Mon, 05/20/13 - 3:07pm
  • InspireMD to Announce 6-Month Results From MGuard Embolic Protection Stent MASTER Trial at EuroPCR
    Mon, 05/20/13 - 10:34am
  • Medtronic Receives CE Mark for Export Advance Aspiration Catheter
    Mon, 05/20/13 - 10:25am
  • St. Jude Medical Announces European Approval of 3-D Vessel Reconstruction Technology to Aid Physicians in Stent Placement
    Mon, 05/20/13 - 10:05am
  • Elixir Medical Receives CE Mark Approval for the Fully Bioresorbable DESolve Novolimus Eluting Coronary Scaffold System
    Wed, 05/15/13 - 10:12am
  • Reverse Medical Corporation Announces CE Mark and Initial Clinical Experience with the MVP Micro Vascular Plug for Peripheral Embolization
    Wed, 05/15/13 - 8:55am
  • St. Jude Medical Announces First Patient Enrollment in EnligHTN III Renal Denervation Study of Next-Generation EnligHTN System
    Wed, 05/15/13 - 8:52am
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • …
  • next ›
  • last »
  • Advertise your Job Here
    For information on posting classified ads, please contact:
    Kimberly Sutkowski, Classified Sales Representative
    (800) 237-7285, ext. 205

Vascular Access: The VDM Clinician Blog

Anticoagulant Treatment of DVT and Preventing DVT-PE Made Easier

Frank J Criado MD FACS FSVM

Retrograde Crossing: When the Front Door Is Locked, Look for Another Way In!

Ajay U. Mhatre MD

Collecting More Data for Vascular Patients

Lawrence A. Garcia MD

A Road Less Traveled: Access in the Right Brachial Artery

Ajay U. Mhatre MD

Endovascular Options for Complex Abdominal Aortic Aneurysms

Robert S. Dieter MD RVT and Aravinda Nanjundappa MD RVT
more »

Vascular Newswire

  • Medtronic IN.PACT Falcon Drug-Eluting Balloon Yields Positive Outcomes in Small Coronary Arteries
    Thu, 05/23/13 - 3:30pm
  • Svelte Drug-Eluting Stent Utilizing New Class of Bioabsorbable Drug Coating Attains 0% Clinically-Driven Events Through 12-Months in First-In-Man Study
    Thu, 05/23/13 - 3:15pm
  • One-Year Data Demonstrates Safe, Rapid, and Sustained Blood Pressure Reduction With EnligHTN Renal Denervation Technology
    Thu, 05/23/13 - 3:14pm
  • Further Data on STENTYS Self-Apposing Stent Reinforces Strength of Clinical Results
    Thu, 05/23/13 - 3:05pm
more »

Clinical Events Calendar

  • EuroPCR 2013
    Tue, 05/21/2013 - Fri, 05/24/2013
    Paris, France
  • European Society for Vascular Surgery European Vascular Trauma Workshop
    Mon, 05/27/2013 - Tue, 05/28/2013
    Sweden
  • Society for Vascular Surgery Vascular Annual Meeting 2013 (SVS)
    Thu, 05/30/2013 - Sat, 06/01/2013
    San Francisco, CA, United States
more »

Poll

Drug-eluting balloons will have a major role in lower-extremity revascularization in the future.:
REVIEW OUR OTHER Cardiology BRANDS

Our other resources for healthcare professionals.

HMP Communications © 2013 HMP Communications

HMP Communications LLC (HMP) is the authoritative source for comprehensive information and education servicing healthcare professionals. HMP’s products include peer-reviewed and non-peer-reviewed medical journals, national tradeshows and conferences, online programs and customized clinical programs. HMP is a wholly owned subsidiary of HMP Communications Holdings LLC. ©2013 HMP Communications